8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001558370-21-012078
Material agreement · New debt or obligation · Unregistered share sale
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading plx-20210824x8k.htm…